-
Signature
-
/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer
-
Issuer symbol
-
COLL
-
Transactions as of
-
13 Aug 2025
-
Transactions value $
-
-$81,147
-
Form type
-
4
-
Filing time
-
15 Aug 2025, 17:08:54 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Dreyer Scott |
EVP & Chief Commercial Officer |
C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON |
/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer |
15 Aug 2025 |
0001746251 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
COLL |
Common Stock |
Options Exercise |
$104K |
+4.86K |
+4.69% |
$21.34 |
108K |
13 Aug 2025 |
Direct |
F1 |
| transaction |
COLL |
Common Stock |
Sale |
-$185K |
-4.86K |
-4.48% |
$38.03 |
104K |
13 Aug 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
COLL |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-4.86K |
-22.88% |
$0.00 |
16.4K |
13 Aug 2025 |
Common Stock |
4.86K |
$21.34 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: